These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 10101881)
21. Deletion mapping of 18q in conventional renal cell carcinoma. Hirata H; Matsuyama H; Matsumoto H; Korenaga Y; Ohmi C; Sakano S; Yoshihiro S; Naito K Cancer Genet Cytogenet; 2005 Dec; 163(2):101-5. PubMed ID: 16337851 [TBL] [Abstract][Full Text] [Related]
22. [Loss of heterozygosity on chromosome 3 in sporadic colorectal carcinoma]. Peng Z; Ling Y; Bai S Zhonghua Yi Xue Za Zhi; 2001 Mar; 81(6):336-9. PubMed ID: 11798895 [TBL] [Abstract][Full Text] [Related]
23. [Detailed mapping and clinical significance of loss of heterozygosity on 9p13-23 in laryngeal squamous cell carcinoma by microsatellite analysis]. Xu XF; Tang PZ; Cheng SJ Ai Zheng; 2003 May; 22(5):452-7. PubMed ID: 12753701 [TBL] [Abstract][Full Text] [Related]
24. Loss of heterozygosity at 3p14.2 in clear cell renal cell carcinoma is an early event and is highly localized to the FHIT gene locus. Velickovic M; Delahunt B; Grebe SK Cancer Res; 1999 Mar; 59(6):1323-6. PubMed ID: 10096566 [TBL] [Abstract][Full Text] [Related]
25. Comparative analysis of loss of heterozygosity of specific chromosome 3, 13, 17, and X loci and TP53 mutations in human epithelial ovarian cancer. Manderson EN; Presneau N; Provencher D; Mes-Masson AM; Tonin PN Mol Carcinog; 2002 Jun; 34(2):78-90. PubMed ID: 12112314 [TBL] [Abstract][Full Text] [Related]
26. Positive correlation between allelic loss at chromosome 14q24-31 and poor prognosis of patients with renal cell carcinoma. Kaku H; Ito S; Ebara S; Ouchida M; Nasu Y; Tsushima T; Kumon H; Shimizu K Urology; 2004 Jul; 64(1):176-81. PubMed ID: 15245966 [TBL] [Abstract][Full Text] [Related]
27. Common regions of deletion in chromosome regions 3p12 and 3p14.2 in primary clear cell renal carcinomas. Lubinski J; Hadaczek P; Podolski J; Toloczko A; Sikorski A; McCue P; Druck T; Huebner K Cancer Res; 1994 Jul; 54(14):3710-3. PubMed ID: 8033088 [TBL] [Abstract][Full Text] [Related]
28. [Allelic loss on chromosome 3p21-26 in nasopharyngeal carcinoma]. Deng L; Jiang N; Tan G Zhonghua Zhong Liu Za Zhi; 1998 Jul; 20(4):248-50. PubMed ID: 10920974 [TBL] [Abstract][Full Text] [Related]
29. High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints. Wistuba II; Behrens C; Virmani AK; Mele G; Milchgrub S; Girard L; Fondon JW; Garner HR; McKay B; Latif F; Lerman MI; Lam S; Gazdar AF; Minna JD Cancer Res; 2000 Apr; 60(7):1949-60. PubMed ID: 10766185 [TBL] [Abstract][Full Text] [Related]
30. Detailed deletion mapping of chromosome arm 3p in breast cancers: a 2-cM region on 3p14.3-21.1 and a 5-cM region on 3p24.3-25.1 commonly deleted in tumors. Matsumoto S; Kasumi F; Sakamoto G; Onda M; Nakamura Y; Emi M Genes Chromosomes Cancer; 1997 Nov; 20(3):268-74. PubMed ID: 9365834 [TBL] [Abstract][Full Text] [Related]
31. Major role for a 3p21 region and lack of involvement of the t(3;8) breakpoint region in the development of renal cell carcinoma suggested by loss of heterozygosity analysis. van den Berg A; Hulsbeek MF; de Jong D; Kok K; Veldhuis PM; Roche J; Buys CH Genes Chromosomes Cancer; 1996 Jan; 15(1):64-72. PubMed ID: 8824727 [TBL] [Abstract][Full Text] [Related]
32. Loss of heterozygosity at the familial RCC t(3;8) locus in most clear cell renal carcinomas. Druck T; Kastury K; Hadaczek P; Podolski J; Toloczko A; Sikorski A; Ohta M; LaForgia S; Lasota J; McCue P Cancer Res; 1995 Nov; 55(22):5348-53. PubMed ID: 7585599 [TBL] [Abstract][Full Text] [Related]
33. [Mapping allelic deletions on the short arm of human chromosome 3 in kidney neoplasms]. Bazov IV; Kazubskaia TP; Ermilova VD; Gar'kavtseva RF; Loginov VI; Zabarovskiĭ ER; Braga EA Mol Biol (Mosk); 2001; 35(3):404-12. PubMed ID: 11443921 [TBL] [Abstract][Full Text] [Related]
34. VHL and FHIT locus loss of heterozygosity is common in all renal cancer morphotypes but differs in pattern and prognostic significance. Velickovic M; Delahunt B; Störkel S; Grebem SK Cancer Res; 2001 Jun; 61(12):4815-9. PubMed ID: 11406557 [TBL] [Abstract][Full Text] [Related]
35. Loss of heterozygosity on chromosomes 3, 9, 13, and 17, including the retinoblastoma locus, in uveal melanoma. Scholes AG; Liloglou T; Maloney P; Hagan S; Nunn J; Hiscott P; Damato BE; Grierson I; Field JK Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2472-7. PubMed ID: 11581185 [TBL] [Abstract][Full Text] [Related]
36. Loss of heterozygosity of chromosome 3p21 is associated with mutant TP53 and better patient survival in non-small-cell lung cancer. Marsit CJ; Hasegawa M; Hirao T; Kim DH; Aldape K; Hinds PW; Wiencke JK; Nelson HH; Kelsey KT Cancer Res; 2004 Dec; 64(23):8702-7. PubMed ID: 15574780 [TBL] [Abstract][Full Text] [Related]
37. Chromosome 17p deletions and p53 mutations in renal cell carcinoma. Reiter RE; Anglard P; Liu S; Gnarra JR; Linehan WM Cancer Res; 1993 Jul; 53(13):3092-7. PubMed ID: 8319216 [TBL] [Abstract][Full Text] [Related]
38. Mapping of genetic deletions on chromosome 3 in colorectal cancer: loss of 3p25-pter is associated with distant metastasis and poor survival. Tsai MH; Fang WH; Lin SH; Tzeng ST; Huang CS; Yen SJ; Chou SJ; Yang YC Ann Surg Oncol; 2011 Sep; 18(9):2662-70. PubMed ID: 21347784 [TBL] [Abstract][Full Text] [Related]
39. Role of chromosome 3p12-p21 tumour suppressor genes in clear cell renal cell carcinoma: analysis of VHL dependent and VHL independent pathways of tumorigenesis. Martinez A; Fullwood P; Kondo K; Kishida T; Yao M; Maher ER; Latif F Mol Pathol; 2000 Jun; 53(3):137-44. PubMed ID: 10897333 [TBL] [Abstract][Full Text] [Related]